(Q44555633)

4 December 2017

title

Pyrazolo-[1,5-a]-1,3,5-triazine corticotropin-releasing factor (CRF) receptor ligands (English)

1 reference

4 December 2017

Paul J Gilligan

1

1 reference

4 December 2017

Beverly K Folmer

2

1 reference

4 December 2017

Richard A Hartz

3

1 reference

4 December 2017

Stephanie Koch

4

1 reference

4 December 2017

Kausik K Nanda

5

1 reference

4 December 2017

Stephen Andreuski

6

1 reference

4 December 2017

Lawrence Fitzgerald

7

1 reference

4 December 2017

Keith Miller

8

1 reference

4 December 2017

William J Marshall

9

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

Bioorganic & Medicinal Chemistry

4 December 2017

published in

1 reference

4 December 2017

volume

11

1 reference

4 December 2017

issue

18

1 reference

4 December 2017

page(s)

4093-4102

1 reference

Corticotropin releasing factor (CRF) receptor modulators: progress and opportunities for new therapeutic agents

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900398-5

7 January 2021

The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900398-5

7 January 2021

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900398-5

7 January 2021

Persistent elevations of cerebrospinal fluid concentrations of corticotropin-releasing factor in adult nonhuman primates exposed to early-life stressors: implications for the pathophysiology of mood and anxiety disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900398-5

7 January 2021

Characterization of the behavioral profile of the non-peptide CRF receptor antagonist CP-154,526 in anxiety models in rodents. Comparison with diazepam and buspirone

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900398-5

7 January 2021

CP-154,526: a potent and selective nonpeptide antagonist of corticotropin releasing factor receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900398-5

7 January 2021

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900398-5

7 January 2021

The role of corticotropin releasing factor in depressive illness: a critical review

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900398-5

7 January 2021

Corticotropin releasing hormone in the pathophysiology of melancholic and atypical depression and in the mechanism of action of antidepressant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900398-5

7 January 2021

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900398-5

7 January 2021

4-(1,3-Dimethoxyprop-2-ylamino)-2,7-dimethyl-8-(2, 4-dichlorophenyl)pyrazolo[1,5-a]-1,3,5-triazine: a potent, orally bioavailable CRF(1) receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900398-5

7 January 2021

Synthesis, corticotropin-releasing factor receptor binding affinity, and pharmacokinetic properties of triazolo-, imidazo-, and pyrrolopyrimidines and -pyridines

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900398-5

7 January 2021

Corticotropin-releasing factor receptors in the rat central nervous system: characterization and regional distribution.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2803%2900398-5

7 January 2021

10.1016/S0968-0896(03)00398-5

Identifiers

DOI

1 reference

4 December 2017

1 reference